These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23392811)

  • 1. [Stereotactic Radiofrequency Ablation (SRFA) of intrahepatic cholangiocellular carcinomas: a minimal invasive alternative to liver resection].
    Bale R; Schullian P; Haidu M; Widmann G
    Wien Med Wochenschr; 2013 Mar; 163(5-6):128-31. PubMed ID: 23392811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma.
    Kim JH; Won HJ; Shin YM; Kim KA; Kim PN
    AJR Am J Roentgenol; 2011 Feb; 196(2):W205-9. PubMed ID: 21257864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Radiofrequency Ablation of an Unresectable Intrahepatic Cholangiocarcinoma (ICC): Transforming an Aggressive Disease into a Chronic Condition.
    Laimer G; Jaschke N; Gottardis M; Schullian P; Putzer D; Sturm W; Bale R
    Cardiovasc Intervent Radiol; 2020 May; 43(5):791-796. PubMed ID: 32162024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent intrahepatic cholangiocarcinoma: single-center experience using repeated hepatectomy and radiofrequency ablation.
    Kamphues C; Seehofer D; Eisele RM; Denecke T; Pratschke J; Neumann UP; Neuhaus P
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):509-15. PubMed ID: 20714840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiofrequency ablation of unresectable intrahepatic cholangiocarcinomas: a retrospective study.
    Haidu M; Dobrozemsky G; Schullian P; Widmann G; Klaus A; Weiss H; Margreiter R; Bale R
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1074-82. PubMed ID: 22006031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extent of resection in surgical therapy of central bile duct carcinomas].
    Jonas S; Bechstein WO; Kling N; Neuhaus P
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1075-7. PubMed ID: 9574337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical therapy of intrahepatic cholangiocellular carcinoma].
    Lang H; Sotiropoulos GC; Brokalaki E; Frühauf NR; Radü J; Paul A; Wohlschlaeger J; Baba HA; Malagó M; Broelsch CE
    Chirurg; 2006 Jan; 77(1):53-60. PubMed ID: 16170505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma.
    Fu Y; Yang W; Wu W; Yan K; Xing BC; Chen MH
    J Vasc Interv Radiol; 2012 May; 23(5):642-9. PubMed ID: 22525022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current management of hilar cholangiocarcinoma.
    Jarnagin WR; Fong Y; Blumgart LH
    Adv Surg; 1999; 33():345-73. PubMed ID: 10572576
    [No Abstract]   [Full Text] [Related]  

  • 10. Aggressive local treatment for recurrent intrahepatic cholangiocarcinoma-Stereotactic radiofrequency ablation as a valuable addition to hepatic resection.
    Braunwarth E; Schullian P; Kummann M; Reider S; Putzer D; Primavesi F; Stättner S; Öfner D; Bale R
    PLoS One; 2022; 17(1):e0261136. PubMed ID: 34982804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermal ablation of intrahepatic cholangiocarcinoma: Safety, efficacy, and factors affecting local tumor progression.
    Takahashi EA; Kinsman KA; Schmit GD; Atwell TD; Schmitz JJ; Welch BT; Callstrom MR; Geske JR; Kurup AN
    Abdom Radiol (NY); 2018 Dec; 43(12):3487-3492. PubMed ID: 29869103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic procedures and results in surgical therapy for cholangiocarcinoma].
    Schüle S; Altendorf-Hofmann AK; Knösel T; Uteß F; Settmacher U
    Zentralbl Chir; 2014 Dec; 139 Suppl 2():e25-34. PubMed ID: 22274918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiofrequency ablation.
    Bale R; Widmann G; Haidu M
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):852-6. PubMed ID: 20734193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation of recurrent cholangiocarcinoma.
    Slakey DP
    Am Surg; 2002 Apr; 68(4):395-7. PubMed ID: 11952256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of cholangiocellular carcinoma.
    Pichlmayr R; Lamesch P; Weimann A; Tusch G; Ringe B
    World J Surg; 1995; 19(1):83-8. PubMed ID: 7740815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
    Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
    Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical therapy of malignant liver tumors: resection and transplantation].
    Weimann A; Raab R; Pichlmayr R
    Internist (Berl); 1997 Oct; 38(10):963-9. PubMed ID: 9432504
    [No Abstract]   [Full Text] [Related]  

  • 19. Ablative technologies for hepatocellular, cholangiocarcinoma, and metastatic colorectal cancer of the liver.
    Hansen PD; Cassera MA; Wolf RF
    Surg Oncol Clin N Am; 2015 Jan; 24(1):97-119. PubMed ID: 25444471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
    Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.